Aquiline Capital Partners (Aquiline), a private investment firm with over $10bn in AUM, has made a majority investment in PharmaForce, a pharmacy solutions provider to hospitals and health clinics. Financial terms of the deal have not been disclosed.
The provider has delivered 340B administration software to over 280 clients since its inception in 2017 and recently launched a pharmacy benefits management offering.
In a press statement, PharmaForce said that, with Aquiline’s backing, it will “accelerate strategic M&A and continue to expand its product capabilities”.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Of the $250bn raised since the end of 2019, approximately 40% came through the ultra-high net worth channel. Goldman Sachs has a $1tn-plus private wealth management business focused exclusively on the ultra-high net worth space, with 16,000 clients.
In a statement, Goldman Sachs said: “The environment in 2024 remains uncertain, but we are confident in the state of our portfolio companies and remain resolutely focused on the basics of value creation, good ownership and being thoughtful about exit opportunities.”
source: Private Equity Wire
Can’t stop reading? Read more
BlackRock posts $205bn inflows as private assets and ETFs drive record $13.5tn AUM
RFL explores Super League stake sale amid private equity interest and expansion plans The Rugby...
Huawei EV partner Seres prepares up to $2bn Hong Kong listing amid IPO revival
Huawei EV partner Seres prepares up to $2bn Hong Kong listing amid IPO revival Seres Group Co.,...
JPMorgan targets $600bn Asia-Pacific expansion amid rising institutional demand
JPMorgan targets $600bn Asia-Pacific expansion amid rising institutional demand JPMorgan Asset...